Clinical Trials Logo

Filter by:
NCT ID: NCT05140525 Not yet recruiting - CTEPH Clinical Trials

Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH

EPIPHANY
Start date: May 31, 2024
Phase: Phase 3
Study type: Interventional

The main goal of this study is to determine the effects of combination medical therapy (Riociguat and Macitentan) and balloon pulmonary angioplasty (BPA) on hemodynamics and right ventricular (RV) function (including advanced assessments of RV-pulmonary artery (PA) coupling from invasive hemodynamics) in participants with inoperable or post-PTE residual CTEPH.

NCT ID: NCT05139329 Not yet recruiting - Chest Pain Clinical Trials

The ORCHESTRATE-Myocarditis Registry

Start date: January 2022
Phase:
Study type: Observational

A retrospective, observational study consisting of patients who presents with typical/atypical chest pain and have an ensuing negative ischemic evaluation

NCT ID: NCT05139238 Not yet recruiting - Clinical trials for Postpartum Preeclampsia

Postpartum Hypertension Study

Start date: August 2024
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess which blood pressure medication (intravenous labetalol or oral nifedipine) works better in treating severely elevated blood pressure in women who have just delivered a baby.

NCT ID: NCT05137912 Not yet recruiting - Clinical trials for Lung Cancer, Non-small Cell

Neoadjuvant Immunotherapy in Advanced NSCLC

Start date: February 1, 2022
Phase:
Study type: Observational

A number of clinical trials have demonstrated the efficacy of immunotherapy prior as neoadjuvant therapy. This study evaluates whether said neoadjuvant immunotherapy may improve improve progression free survival in NSCLC. One such example would be to evaluate either single agent or an immunotherapy combination with chemotherapy. Following this, analysis of biomarkers will be conducted to provide personalization in one's regimen.

NCT ID: NCT05136924 Not yet recruiting - Dry Eye Disease Clinical Trials

IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL

Start date: December 1, 2021
Phase: Phase 2
Study type: Interventional

A Randomized, Controlled, Double-Masked, Two-Arm Investigator-Initiated study to Assess the Efficacy of OC-01 (varenicline) Nasal Spray on signs and symptoms of Dry Eye Disease in subjects following Corneal Collagen Crosslinking (CXL)

NCT ID: NCT05131984 Not yet recruiting - Multiple Sclerosis Clinical Trials

Ocrelizumab Access by Socio-Economic Status

Start date: November 15, 2021
Phase:
Study type: Observational

The primary aim of this project is to determine whether there are differences in access to, efficacy and tolerability of Ocrelizumab in men and women of different racial and ethnic origins and socio-economic backgrounds with RRMS and PPMS in two large academic MS Centers with a high volume of patients on Ocrelizumab. The study is a retrospective analysis of multiple sclerosis patients cared for at Brigham and Women's Hospital and Boston Medical Center who were treated with Ocrelizumab during the 4 year study period.

NCT ID: NCT05129735 Not yet recruiting - Clinical trials for Diabetes Mellitus, Type 2

An Exploratory Investigation to Assess Changes in Quality of Life for Individuals With Type 2 Diabetes After Taking a Meal-replacement Shake.

Start date: September 15, 2022
Phase: N/A
Study type: Interventional

This is an open-label single-arm observational trial to study the effectiveness of a commercially available meal-replacement shake and its effect on the quality of life in individuals with type 2 diabetes.

NCT ID: NCT05129514 Not yet recruiting - Trauma, Brain Clinical Trials

Imaging Lymphatic/Cerebrospinal Fluid (CSF) Drainage From the Head and Neck in Persons With Traumatic Brain Injury: Demonstration of Feasibility and Evaluation of Manual Therapy to Improve Drainage and Facilitate Cognitive Recovery

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a course of daily manual lymphatic drainage over the course of 5 days can improve lymphatic drainage function and cognitive outcomes and to determine whether single sessions of manual lymphatic drainage improves lymphatic drainage in moderate to severe traumatic brain injury (TBI) patients.

NCT ID: NCT05126888 Not yet recruiting - Tourette Syndrome Clinical Trials

SCI-110 in the Treatment of Tourette Syndrome

Start date: February 2024
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy, safety and tolerability of the cannabinoid-based medication SCI-110 compared to placebo in subjects with Tourette syndrome.

NCT ID: NCT05123469 Not yet recruiting - Epilepsy Clinical Trials

Clinical Validation of zEEG, a Wireless EEG Recording System for Pediatric and Adult Patients With Epilepsy

Start date: January 2022
Phase:
Study type: Observational

The purpose of this study is to compare the standard clinical electroencephalography (EEG) device with a new portable wireless EEG device, further referred to as zEEG, made by ZETO®. zEEG was designed to make EEG studies simpler, safer, more comfortable, faster, and less obstructive for the patient, also easier to set up for technicians. Wireless and battery powered, it uses the latest mobile technology. Contrary to the clinical EEG, this headset does not use any glue between the skin and the electrodes. Minor skin irritation may still occur but much less likely than from the collodion glue used in the clinical electrodes. In addition, the zEEG system does not need any gel to be applied to the skin. The zEEG electrodes are dry and disposable. They have never been used on any other head before. No additional risk is involved with setting it up. In addition to the clinically necessary EEG electrodes or intracranial electrodes for long term monitoring, we will place zEEG on the head to compare the sensitivity of the new device to the traditional device. zEEG is proven to meet the standard of clinical system and received an FDA clearance in 2018. If further clinical tests validate its technical parameters and comfort, it may replace traditional clinical EEG systems.